Treatment of neurodegenerative diseases and cancer of the brain using histone deacetylase inhibitors
作者： Richard A. Rifkind , Victoria M. Richon , Paul A. Marks
DOI:
关键词:
摘要: The present application is directed to a method of treating diseases the central nervous system (CNS) comprising administering individual in need treatment therapeutically effective amount an inhibitor histone deacetylase. In particular embodiments, CNS disease neurodegenerative disease. further neurogenerative inherited disease, such as those which are polyglutamine expansion diseases. can be mammal primate or human.
lens.org参考文章(30)
Laszlo Bodai, Judit Pallos, J. Lawrence Marsh, Joan S. Steffan, Leslie M. Thompson, Method for treating neurodegenerative, psychiatric and other disorders with deacetylase inhibitors ,(2002)
Antonio Tito Fojo, Susan Elaine Bates, Histone deacelylase inhibitors in diagnosis and treatment of thyroid neoplasms ,(2002)
Jeffrey Besterman, Zuomei Li, Claire Bonfils, Antisense oligonucleotide inhibition of specific histone deacetylase isoforms ,(2001)
Dvorit Samid, Methods for prevention of cancer using phenylacetic acids and derivatives thereof ,(1995)
Yasushi Iwamoto, Minoru Yoshida, Teruhiko Beppu, Use of trichostatin compounds for treating tumor cells ,(1986)
Ronald Breslow, Richard A. Rifkind, Paul A. Marks, Novel potent inducers of thermal differentiation and method of use thereof ,(1989)
George Sgouros, Victoria M. Richon, Paul A. Marks, Richard A. Rifkind, Use of histone deacetylase inhibitors in combination with radiation for the treatment of cancer ,(2003)
Susan P. Perrine, Compositions and administration of compositions for the treatment of blood disorders ,(2001)
Thomas A Miller, Victoria M Richon, Judy H Chiao, Polymorphs of suberoylanilide hydroxamic acid ,(2008)